Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,700 | 238 | 97.2% |
| Education | $135.27 | 4 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,180 | 57 | $0 (2022) |
| Janssen Biotech, Inc. | $539.40 | 27 | $0 (2022) |
| Coloplast Corp | $247.82 | 10 | $0 (2022) |
| TOLMAR Pharmaceuticals, Inc. | $231.00 | 13 | $0 (2022) |
| Boston Scientific Corporation | $217.79 | 10 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $214.91 | 15 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $205.45 | 14 | $0 (2021) |
| PFIZER INC. | $193.28 | 15 | $0 (2022) |
| ABBVIE INC. | $185.02 | 11 | $0 (2022) |
| NeoTract Inc. | $171.15 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $105.17 | 2 | Boston Scientific Corporation ($57.88) |
| 2023 | $18.95 | 1 | Axonics, Inc. ($18.95) |
| 2022 | $680.29 | 40 | Astellas Pharma US Inc ($97.69) |
| 2021 | $966.30 | 51 | Astellas Pharma US Inc ($218.65) |
| 2020 | $590.64 | 30 | Astellas Pharma US Inc ($234.48) |
| 2019 | $870.92 | 45 | Astellas Pharma US Inc ($135.85) |
| 2018 | $606.18 | 33 | Astellas Pharma US Inc ($176.83) |
| 2017 | $996.60 | 40 | Astellas Pharma US Inc ($316.58) |
All Payment Transactions
242 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $47.29 | General |
| Category: Urology | ||||||
| 08/01/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $57.88 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 03/09/2023 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Urology | ||||||
| 11/22/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Urology | ||||||
| 08/30/2022 | Accord Healthcare, Inc. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Sun Pharmaceutical Industries Inc. | YONSA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Oncology | ||||||
| 08/08/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Oncology | ||||||
| 08/05/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/28/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 07/26/2022 | UROVANT SCIENCES INC | GEMTESA (Drug) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: Urology | ||||||
| 07/22/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: HORMONE THERAPY | ||||||
| 07/15/2022 | Acerus Pharmaceuticals Corporation | Natesto (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Urology Endocrinology Men's Health | ||||||
| 07/02/2022 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $20.08 | General |
| 06/30/2022 | UroGen Pharma, Inc. | — | Food and Beverage | In-kind items and services | $13.20 | General |
| 06/28/2022 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Prostate Cancer | ||||||
| 06/24/2022 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 06/10/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/24/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Oncology | ||||||
| 05/20/2022 | Myovant Sciences Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: HORMONE THERAPY | ||||||
| 05/17/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Urology | ||||||
| 05/10/2022 | Antares Pharma, Inc. | XYOSTED (Drug), TLANDO, NOCDURNA | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/01/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Oncology | ||||||
| 04/29/2022 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.56 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 135 | 143 | $21,366 | $11,039 |
| 2022 | 21 | 1,743 | 2,242 | $361,331 | $108,830 |
| 2021 | 27 | 2,556 | 3,398 | $514,083 | $173,463 |
| 2020 | 31 | 2,602 | 3,419 | $509,720 | $170,142 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $6,758 | $3,778 | 55.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 32 | $5,280 | $3,100 | 58.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $3,350 | $1,387 | 41.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,016 | $1,230 | 61.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,100 | $1,126 | 53.6% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 12 | 15 | $817.00 | $269.89 | 33.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 16 | 19 | $1,045 | $148.20 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 334 | 449 | $109,180 | $35,490 | 32.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 20 | 116 | $79,228 | $15,545 | 19.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 50 | 68 | $27,200 | $10,173 | 37.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $24,332 | $7,664 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 150 | $25,800 | $7,182 | 27.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2022 | 15 | 17 | $13,209 | $5,116 | 38.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 32 | $12,000 | $4,530 | 37.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 17 | 17 | $9,350 | $2,582 | 27.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 26 | 29 | $8,700 | $2,543 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 23 | $7,889 | $2,487 | 31.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 519 | 686 | $6,860 | $2,357 | 34.4% |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | Facility | 2022 | 14 | 15 | $6,885 | $2,335 | 33.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 17 | 17 | $4,250 | $1,785 | 42.0% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2022 | 15 | 15 | $4,755 | $1,779 | 37.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 47 | 50 | $5,300 | $1,544 | 29.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 177 | 211 | $4,009 | $1,369 | 34.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,587 | $1,147 | 32.0% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 17 | 26 | $3,042 | $1,144 | 37.6% |
About Dr. Samuel Kim, MD
Dr. Samuel Kim, MD is a Urology healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1134129679.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Kim, MD has received a total of $4,835 in payments from pharmaceutical and medical device companies, with $105.17 received in 2024. These payments were reported across 242 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($4,700).
As a Medicare-enrolled provider, Kim has provided services to 7,036 Medicare beneficiaries, totaling 9,202 services with total Medicare billing of $463,474. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Lafayette, IN
- Active Since 07/27/2005
- Last Updated 08/11/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1134129679
Products in Payments
- XTANDI (Drug) $495.50
- MYRBETRIQ (Drug) $320.47
- ELIGARD (Drug) $231.00
- Myrbetriq (Drug) $220.66
- PROVENGE (Drug) $214.66
- Xtandi (Drug) $193.61
- Erleada (Drug) $186.55
- XIAFLEX (Biological) $170.26
- ERLEADA (Drug) $159.54
- ZYTIGA (Drug) $151.16
- LUPRON DEPOT (Drug) $137.00
- Urolift - UL400 (Device) $135.62
- REZUM (Device) $111.28
- Nubeqa (Drug) $111.16
- Harmonic (Device) $109.60
- SPEEDICATH (Device) $108.38
- Xofigo (Drug) $103.75
- ORGOVYX (Drug) $94.43
- Axumin (Drug) $86.12
- CONTINENCE CARE (Device) $79.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lafayette
Alexandra Rogers, Md, MD
Urology — Payments: $422,714
Julio Chong, Md, MD
Urology — Payments: $33,092
Timothy Redden, Md, MD
Urology — Payments: $22,908
Dr. William Roth, Md, MD
Urology — Payments: $19,960
Charles Modlin, Md, MD
Urology — Payments: $12,478
Dr. Stanton Regan, M.d, M.D
Urology — Payments: $11,568